Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
James C. Mullen
52 Week High
52 Week Low
Analyzing Editas Medicine's Unusual Options Activity
On Friday, shares of Editas Medicine (NASDAQ:EDIT) saw unusual options activity. After the option alert, the stock price moved down to $40.88. Sentiment: BULLI
— per share
Expected Aug 5, Pre-Market